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Abstract
This review examines the fundamentals of neurogastroenterology that may underlie the 
pathophysiology of functional GI disorders (FGIDs). It was prepared by an invited committee of 
international experts and represents an abbreviated version of their consensus document that will 
be published in its entirety in the forthcoming book and online version entitled Rome IV. It 
emphasizes recent advances in our understanding of the enteric nervous system, sensory 
physiology underlying pain, and stress signaling pathways. There is also a focus on 
neuroimmmune signaling and intestinal barrier function, given the recent evidence implicating the 
microbiome, diet, and mucosal immune activation in FGIDs. Together, these advances provide a 
host of exciting new targets to identify and treat FGIDs, and new areas for future research into 
their pathophysiology.
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In the 8 years since the publication of Rome III there has been rapid expansion in our 
understanding of the fundamentals of neurogastroenterology. What has fueled this advance 
is the desire to integrate basic science research with clinical gastroenterology to better 
diagnose and treat functional gastrointestinal disorders (FGIDs). This research continues to 
shed light on the complex hierarchy of neural, molecular, and cellular interactions that 
control gut function. However, what recent research also has shown is the complex 
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interaction between the host gut wall and the luminal microbial environment that is 
responsible for balancing immune tolerance with protection against pathogenic and 
antigenic material. Neuroimmune function and the mechanisms that regulate mucosal barrier 
function, immune surveillance, innate and adaptive immunity, sensory signaling, and central 
nervous system (CNS) adaptation consequently are the major themes for this review.
The Basis of Brain–Gut Interactions
The GI tract has important barrier and immune functions that interface with the luminal 
microbiota and protect against potential pathogenic and antigenic material. Integral to these 
ostensibly conflicting functions is the ability to monitor events in the gut wall and within the 
gut lumen to orchestrate reflexes that bring about appropriate patterns of motility, secretion, 
and blood flow to digest and absorb or to dilute and expel. GI sensory mechanisms play a 
pivotal role in triggering these reflexes by conveying sensory information to the enteric 
reflex circuits that provide local control and through afferent pathways to the CNS.
Pathways From Gut to Brain
Sensory information is conveyed from the GI tract to the brainstem and spinal cord via vagal 
and spinal (splanchnic and pelvic) afferents, respectively. Most dorsal root ganglion neurons 
innervate somatic structures. It is estimated that the proportion of dorsal root ganglion 
neurons innervating the GI tract range between 3% and −7%. The dominance of somatic 
afferent input to the spinal cord and the convergence of visceral and somatic afferents on 
ascending spinal pathways accounts for the phenomenon of referred pain. In addition, 
afferent fibers from the colon and rectum may converge with fibers from other pelvic organs, 
contributing to cross-organ sensitization between gut, bladder, and reproductive organs that 
often complicates the clinical diagnosis of pelvic pain.1 The low density of innervation, 
convergence with somatic inputs, and viscerovisceral convergence in the spinal cord can 
explain why gut pain generally is localized poorly.
Subtypes of Visceral Afferents
GI afferent fibers terminate within the gut wall mainly as bare nerve endings and are 
classified according to their terminal distribution as mesenteric, serosal, muscular, 
ganglionic (intraganglionic laminar endings), or mucosal endings.2 The location of these 
endings plays an important role in determining the functional properties of the afferent. 
Mucosal afferents respond to distortion of the mucosal epithelium and to luminal chemicals. 
Stretch or distension is effective for stimulating endings in the muscle layers, ganglia, and 
serosa. These endings express an array of membrane receptors and ion channels that 
determine neuronal excitability, mechanosensitivity, and modulation by a host of chemical 
mediators within the GI milieu. Different populations of afferents respond over a range of 
distension volumes from innocuous (physiological) to noxious levels that cause pain. 
Powerful contractions, especially against an obstruction, cause traction on the mesentery and 
is especially painful.
There is a continuous barrage of information projecting from the gut to the CNS. Many 
afferent endings respond to levels of distension that occur as part of normal digestion and 
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these usually go unperceived. Instead, this information is used in reflexes that control 
motility, secretion, blood flow, and other aspects of GI function. In contrast, there are other 
afferents that respond only at high levels of stimulus intensity and function as nociceptors 
that mediate pain. Some afferents (so-called silent or “sleeping” nociceptors) are 
mechanically insensitive under normal circumstances but can be awakened in response to 
inflammation or injury. In patients this process of sensitization can give rise to altered pain 
perception. In some cases, stimuli that normally are innocuous can cause pain (allodynia), 
whereas responses that are painful can become exaggerated (hyperalgesia).
Mechanotransduction
Mechanotransduction refers to the process by which stimulus energy is interpreted by 
sensory nerve endings, leading to the generation of action potentials. There are specific 
molecular mechanisms that underlie mechanotransduction. Moreover, the excitability of the 
afferent ending is determined by various voltage-gated and calcium-dependent ion channels3 
that set gain in the system, and that can change according to external influences leading to 
hypersensitivity.
Sensory endings contain a variety of mechanosensitive ion channels that can convert the 
stimulus energy into action potentials. They respond to membrane deformation, causing 
channels to open or close, carrying ionic currents into or out of the nerve terminal to cause 
depolarization. Three main ion channel families have been identified as mechanosensitive: 
(1) the DEG/ENaC family that includes the acid-sensing ion channels 1, 2, and 3; (2) the 
transient-receptor potential (TRP) channel family; and (3) the 2-pore potassium channel 
family that includes TREK-1 and TRAAK. Different combinations of these channels exist in 
different populations of vagal, pelvic, and splanchnic afferents, suggesting a complex 
heterogeneity in sensory signaling.4
Another mechanism of mechanotransduction occurs when a secondary sense cell releases 
mediators that act on ionotropic or metabotropic receptors to stimulate sensory endings. This 
indirect mechanism relies on close association between afferent endings in the gut wall and 
various other cell types that are a source of these chemical ligands. These include mast cells, 
epithelial cells, enteroendocrine cells, macrophages, interstitial cells of Cajal (ICC), and 
enteric neurons. Considerable attention has been paid to the role of 5-hydroxytryptamine (5-
HT) and adenosine triphosphate in sensory signaling, especially in the context of post-
inflammatory hypersensitivity.5
Luminal Sensing
Some vagal and pelvic afferent endings come into close proximity to the mucosal 
epithelium, but never penetrate through to the lumen. However, their proximity to the 
mucosa exposes them to chemicals absorbed across the mucosal epithelium or released from 
enteroendocrine cells whose apical membrane is exposed to luminal content. This is similar 
to the relationship seen between taste buds in the mouth and gustatory afferents and as such 
provides a mechanism by which mucosal afferents can taste luminal contents. This is 
important for controlling digestive function via reflex effects on motility and secretion. 
However, nutrient detection also influences metabolic activity and energy intake. The 
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molecular basis for each modality of gustatory taste has been identified. Strikingly, many of 
these same G-protein–coupled receptors and ion channels are expressed within the GI tract. 
The cells expressing taste-receptor molecules in the GI mucosa have a characteristic 
morphology, which is typified by the enterochromaffin (EC) cell.6 However, EC cells are 
just one of a diverse family of enteroendocrine cells that are scattered diffusely in the GI 
mucosa and whose mediators can act in a paracrine fashion on afferent fibers or diffuse into 
the blood stream for more distant endocrine actions. Each type of enteroendocrine cell has a 
characteristic distribution along the GI tract. Among the mediators released, cholecystokinin 
and glucagon-like peptide-1 play important roles in reflex control of GI function and in 
regulating food intake.
Peripheral Sensitization
Sensory neurons express a large array of receptors that are activated by mediators released 
from various cellular sources within the gut wall. Neurotrophins, for example, play a role in 
axon guidance and remodeling of the sensory innervation after inflammation and injury. 
Their receptors are expressed on different populations of GI sensory neurons. Both nerve 
growth factor and glial-derived neurotrophic factor are important in the adaptive response to 
nerve injury and inflammation. Both also are possible mediators underlying chronic pain. 
Increasing neurotrophin signaling causes increased TRP channel expression (eg, TRPV1 and 
TRPA1), an increase in sodium channel expression (NaV1.87), and a decrease in potassium 
channels. Any, or all of these, could contribute to the development of hypersensitivity.8
Many other mediators are released during inflammation, injury, and ischemia, from platelets, 
leukocytes, lymphocytes, macrophages, mast cells, glia, fibroblasts, blood vessels, muscle, 
and neurons. Some mediators act directly on sensory nerve terminals and others act 
indirectly, causing release of yet other agents from nearby cells. This “inflammatory soup” 
(Figure 1) contains amines, purines, prostanoids, proteases, cytokines, and so forth, which 
act on sensory nerve terminals to increase sensitivity to both mechanical and chemical 
stimuli (referred to as “plasticity”). Recent data have suggested that bacterial products also 
may drive afferent signaling.9 Hypersensitivity is a feature of chronic pain states and is 
considered to be a hallmark of FGIDs including irritable bowel syndrome (IBS). Moreover, 
because these afferents also trigger reflexes that coordinate gut function, sensitization also 
can cause hyper-reflexia or dysreflexia, leading to altered transit, resulting in diarrhea and 
constipation.
Peripheral sensitization normally develops rapidly and is relatively short-lived. However, in 
the presence of maintained injury or inflammation, the sensitization can be prolonged by 
changes in gene expression. These genes may alter the expression of channels, receptors, or 
mediators in the sensory neuron.8 They also may modify the amount and pattern of 
neurotransmitters released by central nerve terminals in the brain and spinal cord. This alters 
the way that sensory signals are processed within the CNS and contributes to “central 
sensitization,”10 and may prolong hypersensitivity beyond the acute period of injury or 
inflammation.
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Central Sensitization
These mechanisms can undergo plasticity in response to injury and inflammation, leading to 
hypersensitivity and chronic pain states. These neurons transmit visceral signals to 
ascending spinal pathways via glutamate and neuropeptides. These transmitter mechanisms 
are up-regulated in response to inflammation and injury and contribute to hypersensitivity.
In the brain and spinal cord there are central neuroplastic changes, termed central 
sensitization, that contribute to chronic pain. Within the dorsal horn of the spinal cord, there 
are 2 mechanisms that increase pain signals reaching the brain: (1) increased synaptic 
transmission via glutamate, calcitonin gene-related peptide, and substance P onto ascending 
excitatory pathways, and/or (2) decreased descending inhibitory modulation. In the brain, 
sensitization can occur in the second-order spinal neurons, such as the thalamus, 
periaqueductal gray (PAG), parabrachial nucleus, and locus coeruleus. Increased signaling 
from those nuclei then can promote neuroplasticity, similar to long-term potentiation 
mechanisms, that strengthen and/or add synaptic connectivity. The enhanced signaling then 
promotes abnormal processing of pain within the extended pain matrix (prefrontal cortex 
[PFC], anterior cingulate cortex, amygdala, insula), which can amplify the discomfort and 
negative emotions associated with chronic visceral pain,11 and/or a decrease in the 
descending pain inhibitory system through the PAG and rostroventral medulla.12 In 
particular, the amygdala is a key nucleus that integrates noxious visceral signals with 
anxiety/fear behaviors and hyperactivation could influence not only multiple nuclei in the 
central pain matrix, but also descending brainstem nuclei that modulate GI function.13 
Multiple clinical imaging studies also have shown differences in function, connectivity, and 
structure between IBS and healthy controls. Thus, central sensitization can promote chronic 
abdominal pain in IBS through remodeling of connections within both the brain and spinal 
cord.
ENS Neurobiology
A universal perception of the enteric nervous system (ENS) as a brain-in-the-gut implies 
that, similar to the brain and spinal cord, the ENS is assembled in a hierarchy of neural 
organization.14,15 Output from the ENS determines moment-to-moment behavior of the 
gastrointestinal musculature, secretory glands, and blood vasculature. Integration of output 
to the muscles and secretory glands is reflected by coordinated patterns of motility and 
secretion, recognizable during clearly defined digestive states. Five different behavioral 
states are recognizable in the small intestine: (1) physiological absence of motility; (2) 
postprandial state with segmenting (mixing) motility integrated with set-point feedback 
control of luminal pH and osmolarity; (3) migrating motor complex in the interdigestive 
state also integrated with set-point feedback control of luminal pH and osmolarity; (4) a 
defensive state with copious neurogenic hypersecretion and orthograde or retrograde power 
propulsion associated with urgency, diarrhea, and cramping abdominal pain; and (5) emetic 
program, which includes reversal of peristaltic propulsion in the upper jejunum and 
duodenum to rapidly propel luminal contents toward the open pylorus and relaxed antrum 
and corpus. Coordinated neurogenic patterns of behavior in the large intestine are 
recognized as haustral formation, physiological absence of motility, defecatory power 
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propulsion and defense that also is associated with urgency, diarrhea, and cramping lower 
abdominal pain.
Similar to the CNS, the ENS functions with chemical synaptic connections between sensory 
neurons, interneurons, and motor neurons. Interneurons are interconnected synaptically into 
neural networks, which process information on the state of the gut, contain a library of 
programs for different patterns of behavior, and control the activity of motor neurons. Motor 
neurons innervate the musculature, secretory glands, and blood vessels. Musculomotor 
neurons initiate or inhibit the contractile activity of the musculature when they fire.15 
Modulation of their firing frequency, by input from interneuronal microcircuitry, determines 
minute-to-minute contractile strength. Secretomotor neurons stimulate secretory glands to 
secrete chloride, bicarbonate, and mucus,16,17 and determine the osmolarity and liquidity in 
the lumen. Neurogenic control of bicarbonate secretion maintains a physiological pH set-
point in the lumen and accounts for some of the mucosal protection against acid delivery 
from the stomach. A subset of secretomotor neurons simultaneously innervates both 
secretory glands and periglandular arterioles, and thereby enhance blood flow with 
secretion.
Interaction of the ENS with ICC18 is a major determinant of each of the motility programs 
stored in its library. Electrically conducting junctions (gap junctions) connect smooth muscle 
fibers one to another to form a functional electrical syncytium. Action potentials propagate 
from muscle fiber to muscle fiber in 3 dimensions and trigger a contraction as they enter 
each neighboring muscle fiber. ICC are non-neuronal pacemaker cells that also connect one 
to another to form electrical syncytial networks that extend around the circumference and 
throughout the longitudinal axis of the small and large intestine. The ICC networks generate 
electrical pacemaker potentials (also called electrical slow waves) that spread via gap 
junctions into the intestinal circular muscle, where they depolarize the muscle to action 
potential threshold and thereby trigger contractions.
The functional characteristics of the circular muscle as a self-excitable electrical syncytium 
implies that ICC networks should continuously evoke contractions that spread in 3 
dimensions throughout the entire syncytium, which is in effect the entire length of the 
intestine. Nonetheless, in the normal bowel, long stretches of intestine are found in a state of 
physiological ileus. Attention to the functional electrical syncytial properties of the 
musculature suggests that inhibitory musculomotor neurons and control of their activity by 
the integrative microcircuits in the ENS have evolved as a mechanism that determines when 
ongoing slow waves initiate a contraction, as well as the distance and direction of 
propagation after the contraction starts.
Overall, a normal ENS is essential for a healthy bowel and absence of irritating symptoms, 
such as those associated with Rome-based diagnostic criteria for FGIDs. Any neuropathic 
change in the ENS most likely will result in a symptomatic bowel. Functional propulsive 
motility and its integration with specialized secretory functions cannot work in the absence 
of the ENS, as underscored in the aganglionic terminal segment of Hirschsprung’ s disease 
and autoimmune ENS denervation of the lower esophageal sphincter in achalasia.
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ENS Neuroplasticity in Pathophysiological Conditions
Gut functions are altered under various pathophysiological conditions, and it has become 
increasingly clear that alterations in the intrinsic reflex circuits of the gut are involved. Over 
the past decade, much progress has been made toward determining what elements of the 
circuits are altered, the mechanisms of these alterations, which changes persist after recovery 
from inflammation, and the effects of neuroplasticity on propulsive motility.
Mucosal Serotonin Signaling
One mechanism of activating enteric neural reflex circuits is the release of 5-HT from EC 
cells in the intestinal mucosa.19 Serotonin released from EC cells activates intrinsic enteric 
reflexes and also sends signals related to digestive reflexes, satiety, and pain to the CNS via 
vagal and spinal afferents. Serotonin signaling is terminated by reuptake into epithelial cells, 
all of which express the serotonin selective reuptake transporter (SERT) on their basal 
surface. A consistent feature of mucosal 5-HT signaling in the inflamed bowels of human 
beings and experimental animals is a decrease in SERT expression.19 This has been shown 
in ulcerative colitis and diverticulitis in human beings, and also in diarrhea-predominant and 
constipation-predominant IBS. The effects of decreased SERT expression are likely to be 
comparable with those related to serotonin-selective– receptor inhibitor use, with increased 
mucosal 5-HT availability resulting in alterations in gut reflexes.
Decreased SERT expression in the inflamed bowel is likely to involve the actions of the 
proinflammatory cytokines, tumor necrosis factor a, and interferon ?.20 The contributing 
factors for decreased SERT in IBS have not been identified, but it may involve a genetic 
predisposition, given that certain polymorphisms of the SERT gene are associated with 
decreased SERT expression. It also is possible that altered SERT expression in IBS develops 
as a compensatory response to altered gut function; however, SERT expression is not altered 
in opiate-induced constipation.21
Impact of Enteric Neuroplasticity on Gut Functions
Inflammation is associated with changes along the ENS reflex circuitry that include 
increased 5-HT availability, hyperexcitability of AH (sensory) neurons, interneuronal 
synaptic facilitation, and suppressed purinergic neuromuscular transmission22 (Figure 2). It 
is highly likely that these alterations lead to changes in neurogenic secretory and motor 
functions in the bowel, but the nature of the changes probably differs between secretory and 
motor responses. Neurogenic secretion can be activated by 5-HT release from EC cells, and 
involves a 2-neuron reflex circuit consisting of an AH neuron and an S neuron. With 
increased 5-HT availability, AH neuron hyperexcitability, and a strengthening of synaptic 
signals to the secretomotor (S) neurons, it is likely that secretion is enhanced. One potential 
pitfall in this scheme is that 5-HT receptors on the processes of AH neurons could become 
desensitized by increased exposure to 5-HT.
The effects of neuroplastic changes on motility are more convoluted than secretion because 
the reflex circuitry is more complicated, involving an excitatory signal passing upstream 
from a given site and an inhibitory signal passing downstream. For an unequivocal set of 
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signals to be transmitted, there cannot be much noise in the system. This quiescent 
background state is disrupted in the inflamed colon by increased 5-HT availability in the 
lamina propria and by increased spontaneous activity of AH neurons throughout the 
inflamed regions. This results in an overlap of contradictory ascending and descending 
signals at a given site, and a decrease in the ability of the ENS to generate the pressure 
gradient that result in propulsive motility, resulting in a form of pseudo-obstruction. 
Experimentally, increasing AH neuron excitability in normal colons disrupts motility 
whereas suppressing hyperexcitability of AH neurons in inflamed preparations improves 
motility.23 Furthermore, when the inhibitory junction potential is protected and AH neuron 
activity is attenuated in trinitrobenzene sulfonic acid–inflamed colons, propulsive motility is 
restored to its control velocity.24 These findings underscore the delicate balance of enteric 
neural signaling, especially as it relates to motor functions.
Neuroimmune Cross-Talk
No perfect animal model exists for investigating the neurophysiological basis of altered 
motility in FGIDs, but one approach that has been used is to determine what inflammation-
induced neuroplastic changes persist beyond the recovery of inflammation. This approach is 
obviously relevant to postinfectious IBS, but in the past decade a number of studies have 
shown that IBS is accompanied by a detectable increase in immune cells and inflammatory 
mediators in the mucosal layer. Furthermore, many inflammatory bowel disease patients 
show IBS-like symptoms after resolution of their macroscopic inflammation. Therefore, 
inflammation-induced changes in neuronal function could be a contributing factor in IBS 
and refractory inflammatory bowel disease, but these changes in neuronal excitability and 
synaptic strength would not be detectable with current diagnostic techniques. Several 
inflammation-induced changes in the ENS, including AH neuron hyperexcitability, do 
persist beyond recovery of inflammation,25,26 supporting the possibility that long-term 
changes in enteric circuitry could contribute to FGIDs.
Neuroimmune Function
For many years, the contribution of immune cells to the pathogenesis of FGIDs largely was 
ignored. Recent evidence derived from patient and animal studies, however, has shown the 
untapped therapeutic potential of the mechanisms involved in the cross-talk among immune 
cells, epithelial cells, smooth muscle, enteric nerves, and their role in the generation of 
symptoms in FGIDs.
The intestine is a unique compartment containing enteric neurons and a large number of 
regionally distributed resident immune cells. The expression of receptors for 
neurotransmitters on immune cells, and receptors for immune mediators on neurons/nerves, 
provides a foundation for neuroimmune interactions (Figure 3). Immune cells synthesize and 
release mediators that alter neuronal activity though neural expression of receptors for 
pathogen- and damage-associated molecules and for cytokines generated by resident and 
infiltrating cells. Immune cells also release classic neurotransmitters, fostering the concept 
of the “neuroimmune synapse.” Neuroimmune cross-talk is involved in proinflammatory and 
anti-inflammatory neural reflexes and is important for the full development of the gut 
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immune system and maintenance of mucosal homeostasis. Amplification of the bidirectional 
communication among epithelial cells, innate and adaptive immune cells, and ENS provides 
a bridge to the adaptive immune response to physiologic or pathogenic stimuli.
Cells Involved in Neuroimmune Interactions
Intestinal epithelial cells—Intestinal epithelial cells (IECs) express pattern recognition 
receptors (PRRs), including membrane-spanning Toll-like receptors, intracellular nucleotide 
oligomerization domain-like receptors, and retinoic acid-inducible gene 1–like receptors, all 
of which respond to pathogen-derived signals to promote tissue-specific innate immunity. 
Epithelial-derived cytokines (eg, interleukin [IL]25, thymic stromal lymphopoietin) activate 
receptors on resident immune cells to initiate immune responses. IECs also amplify immune 
responses by producing chemokines, such as IL8, that recruit immune cells. Immune 
mediators binding to IEC receptors affect function through a variety of signaling pathways 
or through activation of transcription factors that control expression of specific genes. The 
close association of epithelial cells, nerves, and immune cells greatly facilitates their 
interactions.
Intraepithelial lymphocytes—Intraepithelial lymphocytes (IELs) are a heterogeneous 
population of T-cell subtypes—distinct from peripheral T cells—that are interspersed among 
IECs. IELs express surface markers that play a role in their migration and retention in the 
mucosal compartment and generate molecules, allowing them to tether epithelial cells. In 
human beings, the majority of IELs are found in the proximal small intestine where they are 
important in mucosal tolerance and in maintenance of barrier function through the 
production of cytokines that affect permeability.27
Innate lymphoid cells—Innate lymphoid cells (ILCs) are a recent discovery, arise from a 
poorly defined precursor pool, and generate cytokines identified with polarized adaptive 
immune responses (T-helper [Th]1, Th2, or Th17). Unlike T cells, ILCs lack antigen 
receptors and are not involved in immune memory,28 but are important for the initiation of 
host immune responses. ILC fate is modulated by the cross-talk among epithelial cells, 
luminal factors, and other immune cells, implicating them in both protective and 
inappropriate immune responses.29
Dendritic cells—Intestinal dendritic cells (DCs) shape adaptive immune responses to 
harmful or infectious intraluminal stimuli through acquisition of luminal antigens and 
migration to mesenteric lymph nodes to present these antigens to naive T cells. Sensory 
neuropeptides participate in the recruitment of DCs during neurogenic inflammation, and 
activation of vasoactive intestinal polypeptide (VIP) receptors inhibits the migration of 
mature DCs to sites of inflammation, inducing a more tolerogenic phenotype. DCs express 
nicotinic and dopaminergic receptors that shift function toward production-specific profiles 
of cytokines and this neuromodulation may play a role in inflammatory GI pathologies.
T cells—As central constituents of the adaptive immune response, T cells are natural 
targets of the nervous system. Specific cell markers subdivide populations of effector T cells 
into different phenotypes including cytotoxic (CD8+), T helper (CD4+), memory (CD4+ or 
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CD8+, CD45RO), and regulatory (CD25+). Some effector cells are retained and differentiate 
into resident tissue memory cells, which are responsible for rapid responses to subsequent 
antigenic stimuli. T cells express receptors for neurotransmitters including 5-HT, dopamine, 
norepinephrine, glutamate, and acetylcholine (muscarinic and nicotinic). Their ability to 
release acetylcholine and produce choline acetyltransferase allows them to function as a 
non-neuronal cholinergic system.30
Mucosal mast cells—Mucosal mast cells reside in healthy gut and are important in the 
transition from innate to adaptive immunity. They release both preformed and newly 
synthesized mediators including proteases, histamine, prostaglandins, 5-HT, cytokines, and 
chemokines that depend on the phenotype, which is influenced by the microenvironment. 
The nature and timing of mediator release is determined by the type of receptors activated 
and the strength and duration of the stimuli. There is a well-documented anatomic and 
functional interaction between mucosal mast cells and nerves.
Macrophages—Macrophages are the largest population of mononuclear phagocytes in the 
gut. Mucosal macrophages respond to luminal contents and to specific IEC-derived 
mediators. Macrophages associated with smooth muscle are implicated in inflammation- and 
infection-induced changes in gut motility.31 Macrophage activation by Th1 cytokines leads 
to the development of the proinflammatory classically activated phenotype, whereas Th2 
cytokines promote the development of the anti-inflammatory alternatively activated 
phenotype. Macrophages express nicotinic and muscarinic receptors for acetylcholine and 
are in close contact with cholinergic neurons. Activation of these receptors enhances or 
inhibits macrophage phagocytosis and modulates production of cytokines. Macrophages also 
express ?- and ?-adrenergic receptors as well as receptors for 5-HT, substance P, VIP, 
adenosine, and a number of proteases that activate protease-activated receptor 1 and 
protease-activated receptor 2.
Immune Modulation of Integrated Neural Responses
Activation of vagal nerves has beneficial effects that include inhibition of proinflammatory 
cytokines and attenuation of tissue injury. Recent evidence has shown an anatomic and 
functional interaction between macrophages in the muscularis externa of the intestine with 
vagal efferent fibers synapsing on cholinergic, nitric oxide, and VIP-containing neurons in 
the ENS.32 Sympathetic nerves innervate gut-associated lymphoid structures and modulate 
the responses of immune cells expressing adrenergic receptors. Proinflammatory actions of 
sympathetic nerves are mediated by ?2-adrenergic receptors whereas anti-inflammatory 
effects are mediated by the ?3-adrenergic receptor. Catecholamines bind with higher affinity 
to ? than to ? receptors, so the distance from the source of the immune cells that express 
both receptors can influence the response.
Neurogenic inflammation is a response triggered by serine proteases, elaborated by enteric 
pathogens, mast cells, and neutrophils. Cleavage of protease-activated receptor 2 on extrinsic 
primary afferents sensitizes TRP channels and releases proinflammatory sensory 
neuropeptides such as substance P and calcitonin gene-related peptide. There is also a 
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neuronal and nerve fiber hyperplasia in inflammation that also may contribute to the severity 
of the response.33
Interaction of the Epithelial Barrier and the ENS With Gut Luminal Content
The intestinal epithelial barrier plays a critical role in the maintenance of homeostasis within 
the gut and there is growing evidence that alterations in this barrier may be an important 
factor in the pathogenesis of FGIDs. The epithelium, along with underlying immune 
structures in the lamina propria, plays a pivotal role in controlling the host immune response 
to luminal antigens. These luminal factors also may signal directly or indirectly, through the 
host immune response, to other effector systems including the ENS. These complex 
interactions, if dysregulated, can lead to gut dysfunction and symptom onset.
Intestinal Barrier Structure
The intestinal barrier (Figure 4) consists of a single layer of epithelial cells that physically 
separates the host from the intestinal lumen.34 IECs are bound together by the epithelial 
apical junctional complex, comprised of tight junctions, adherens junctions, and other 
membrane complexes containing the membrane proteins nectin and junctional adhesion 
molecule. Overlying the apical side of epithelial cells is a mucus layer primarily produced 
by goblet cells, antimicrobial peptides, and immunoglobulins.35
Intestinal Barrier Function
Water and ion transport—The gut is capable of handling approximately 9 L of fluid per 
day, absorbed mainly by the small intestine. This fluid movement involves both absorptive 
and secretory processes, which can occur through the paracellular or the transcellular route. 
The paracellular pathway involves water movements coupled to nutrient absorption (solvent 
drag), whereas the transcellular route involves the passage of water through apical and 
basolateral membranes of epithelial cells by passive diffusion, cotransport with ions and 
nutrients, or through aquaporins.
Antigen sampling—Immune sampling of luminal content is constant and key to mount an 
appropriate immune response. Peyer’ s patches are overlaid with specialized epithelial cells 
called microfold cells, through which antigens are transported and exposed to antigen-
presenting cells in the lamina propria. Direct sampling may occur through extension of 
dendrites by specialized dendritic cells. This process mainly occurs in the ileum, whereas in 
the upper small intestine sampling may be more dependent on changes in paracellular 
permeability.
Immune defense—Gastric and intestinal secretions, and peristalsis, aid in digestion and 
immune defense by flushing microbes and toxins. The outer layer of mucus in the colon 
traps and contains large numbers of bacteria whereas the inner layer is maintained relatively 
sterile, in part by antimicrobial proteins (defensins, cathelicidins, proteases, and C-type 
lectins) produced by various enterocytes, Paneth cells, and innate immune cells. Some 
antimicrobial proteins are expressed constitutively and others are dependent on intestinal 
microbial colonization. Epithelial cells also transport IgA produced by B cells into the gut 
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lumen. IgA deficiency is associated with increased penetration of bacteria into host 
tissues.36 Epithelial cells also are armed with antigen detection and immune signaling 
mechanisms, and in some cases can even act as antigen-presenting cells for neighboring 
IELs.
Molecular Mechanisms of Interactions Between the Intestinal Barrier and Luminal 
Antigens
A key process in innate recognition of microbial antigens is mediated by pattern recognition 
receptors (PRRs), which include Toll-like receptors (TLRs), nucleotide binding 
oligomerization domain-like receptors, RNA helicases, C-type lectin receptors, and cytosolic 
DNA sensors. These receptors recognize evolutionary conserved pathogen-associated 
molecular patterns expressed by various microorganisms, and shared by symbiotic 
microorganisms. Both epithelial and immune cells express PRRs. Upon activation, PRRs 
trigger sequential activation of intracellular signaling pathways and lead to induction of a 
range of cytokines and chemokines that promote immune and physiological responses. PRR 
signaling also facilitates the differentiation of T cells and B cells to establish antigen-specific 
adaptive immunity.
Critical intestinal barrier adaptations occur in response to microbial signals after gut 
colonization.37 In germ-free animals, expression of antimicrobial peptides is negligible, low 
levels of IgA are secreted, the composition of the mucus is altered, TLR expression is 
reduced, and zonula occludens 1 proteins are diminished. After bacterial colonization, there 
is expansion of the lamina propria, along with increased cell proliferation and increased 
expression of innate microbial recognition receptors.
Interaction of the Intestinal Barrier With Luminal Content
Gut microbiota—A key strategy of the mammalian intestine in maintaining homeostasis is 
to regulate the interaction between luminal microbiota and the intestinal epithelial cell, as 
well as immune surveillance cells in the barrier. However, disruption of the epithelial barrier, 
for example, during acute gastroenteritis, could allow signaling by the microbiota directly to 
the immune system in the lamina propria and possibly directly to enteric and nerve terminals 
of dorsal root ganglia neurons. Multiple TLRs also are found on enteric and autonomic 
neurons and TLR activation can affect their excitability.
Food components—There is increasing recognition that luminal food components 
induce symptoms in many patients with FGIDs.38 Enhanced signaling resulting from altered 
intestinal barrier and/or exaggerated neuroimmune responses could underlie these actions. 
One important component is sensitivity to wheat-containing diets in some IBS patients. This 
sensitivity could be related to gluten because the gluten-derived peptide P31–43 increased 
IL15-positive cells from biopsy specimens from celiac patients and induced stress markers 
on epithelial cells. Other studies have shown that gliadin, the storage protein in gluten, 
increases permeability, and studies in animal models of gluten sensitivity have shown that 
gliadin or gluten can increase permeability, which then leads to increased uptake of 
microbiota antigens that further amplify the immune and functional responses to gluten. 
Other components in wheat are capable of inducing innate immune responses that could lead 
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to gut dysfunction. Amylase trypsin inhibitors that protect the grain from pests can activate 
the TLR-4 pathway. Interestingly, amylase trypsin inhibitor reactivity has been implicated in 
allergy and Baker’ s asthma. Whether amylase trypsin inhibitors alter the epithelial barrier 
and play a role in a proportion of wheat-related IBS symptoms remains unknown, but may 
explain some allergic reactions to wheat components that potentially could lead to mast cell 
degranulation and symptoms. Another important component is the carbohydrates and 
smaller amounts of protein that are not absorbed in the small intestine. These are 
metabolized by colonic bacteria to short-chain fatty acids and intestinal gases. Studies 
suggest fermentable substances can cause colonic epithelial cells to express receptors for 
these short-chain fatty acids, potentially altering the properties of enteric neurons, leading to 
changes in motility and secretion. Fermentable food components also produce a number of 
gases, including H2, CH4, and CO2, which could produce symptoms as a result of the gas-
induced distension of the colon and secondary activation of neural reflexes. H2S gas, 
produced by sulfur-reducing bacteria in the intestinal lumen, also has been implicated in the 
regulation of gut function, including secretion, motility, and nociceptive signaling. Finally, 
attention recently has centered on bile acids, particularly in diarrhea-predominant IBS 
patients, in whom such acids may induce alterations in intestinal physiology, by signaling to 
the epithelium, immune cells, blood vessels, smooth muscle, ENS, and autonomic nerves.
Stress
Although the etiology of FGIDs is unknown, there is compelling evidence that psychological 
and physical stressors play an important role (Figure 5). It is a generally accepted hypothesis 
that dysfunction of the bidirectional communication between the brain and the gut, in part 
through activation of the principal neuroendocrine stress system, namely the hypothalamic–
pituitary–adrenal (HPA) axis, plays a role in the symptomatology of IBS. The HPA axis is 
activated by stress, causing the release of corticotropin releasing factor (CRF) from the 
paraventricular nucleus of the hypothalamus into the hypophyseal portal circulation to bind 
in the anterior pituitary. Adrenocorticotropic hormone then is released from the pituitary into 
the systemic circulation to cause the synthesis and release of the glucocorticoid cortisol 
(corticosterone in rats) from the adrenal cortex. Clinical studies have implicated HPA axis 
dysregulation based on multiple reports of increased cortisol levels and exaggerated HPA 
responses to stressors in IBS patients.
Multiple lines of evidence have shown activation of central mechanism(s) resulting in 
colorectal hypersensitivity, involving descending facilitation from the brain to induce 
remodeling of colorectal responsiveness via sensitization of spinal dorsal horn neurons. 
Brainstem regions responsible for the modulation of descending inhibitory pain signals are 
modulated by both pain and stress. The PAG receives excitatory signaling from the PFC and 
inhibitory signaling from the amygdala. The rostroventral medulla receives not only direct 
nociceptive information from the spinoreticular pathway but also integrated pain and stress 
signals from the amygdala and PAG. In addition, the locus coeruleus and amygdala form a 
circuit that can potentiate both endocrine and autonomic stress responses. Central structures 
regulating affective and sensory processes including the amygdala, insula, cingulate, and 
PFC show enhanced activation in IBS patients. In animal models and in IBS patients, 
imaging studies have shown that limbic regions regulating sensory processing and emotion, 
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including the amygdala, show greater responsiveness to visceral stimulation. The amygdala 
is an important limbic structure involved in the potentiation of the HPA axis, with diffuse 
connections to pain-modulatory networks, and has been implicated in visceral sensitivity and 
aberrant HPA activity observed in IBS patients.13 The amygdala is sensitive to 
corticosteroids but, in contrast to the hippocampus and PFC, the amygdala facilitates 
behavioral, neuroendocrine, and autonomic responses to stress. Thus, this altered balance in 
stress modulation induced by amygdala hyperactivity may represent an essential aspect of 
alterations in GI motor function, colonic permeability, and colorectal sensitivity apparent in 
IBS. In support, increasing amygdala corticosterone in rats by stereotaxically implanting 
corticosterone micropellets onto the central nucleus of the amygdala causes a persistent 
increase in the sensitivity to visceral stimuli as well as inducing anxiety-like behavior.39 
These findings suggest that in IBS patients exposed to chronic stress, increased amygdala 
activation dysregulates the HPA axis.
Clinical observations have suggested that abdominal pain and altered bowel habits are more 
common in females, and that menstrual cycle–linked differences are observed in symptom 
reporting. Differences in CNS processing of visceral information is a potential explanation 
because studies using positron emission tomography imaging have suggested that gender 
differences in regional brain responses to rectal pressure exist in IBS patients. Differences in 
pain sensitivity may be the result of cyclic hormonal changes in females, however, the 
mechanisms are poorly understood. Effectively abolishing the activational role of ovarian 
hormones via ovariectomy reverses the effects of early life adversity (ELA) on adult visceral 
pain hypersensitivity in female rats, whereas reintroduction of ovarian hormones via a 
subcutaneous estradiol pellet was sufficient to induce visceral hyperalgesia.40 These data 
provide support that ovarian hormones play a prominent role in maintaining the persistent 
effects of ELA on increased pain sensitivity in human beings and rodent models. Studies of 
neonatal maternal separation to induce ELA also have shown features of the IBS phenotype 
including motility abnormalities, colonic hypersensitivity, and enhanced gut permeability.40
Remodeling of the epigenome by the environment or chronic stress may result in long-term 
changes in gene expression.41 A recent study showed the importance of histone acetylation 
in stress-induced visceral pain by showing that direct administration into the brain of a 
histone deacetylase inhibitor reversed visceral hypersensitivity induced by stress or 
activation of the amygdala with corticosterone.42,43 In another study, exposure to ELA was 
associated with CRF promoter hypomethylation and an increase in CRF transcriptional 
responses to stress in adulthood suggesting that neonatal stress causes long-lasting 
epigenetic changes in the CRF expression within the HPA axis.44
In summary, stress plays an important role in functional bowel disorders with recent 
evidence from experimental models showing that chronic adult stress or early life stress can 
recapitulate IBS phenotypes, and provide new insights into the underlying mechanisms of 
IBS.
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Conclusions and Future Directions
This review highlights many advances in our understanding of the cellular and molecular 
mechanisms underlying GI physiological and pathophysiological systems that may play a 
role in FGIDs. Examples of important themes and research questions for future research are 
as follows:
1. Sensory mechanisms underlying sensitization of nociceptors and visceral 
hypersensitivity: which mediators act to sustain signaling in specific patients and 
are there critical pathways? When and how are central (CNS) and peripheral 
mechanisms (ENS/autonomic nervous system) dominant?
2. Barrier function regulating intestinal permeability, tight junction proteins, and 
microbiome signaling: which pathways are involved in FGIDs and when? Which 
mechanisms regulate them?
3. Neuroimmune function regulating immune mediators and bidirectional neural 
signaling: which immune cells are activated and which mediator(s) are most 
important? What role do the vagal anti-inflammatory/ sympathetic 
proinflammatory and central pathways play?
4. ENS preprogrammed synaptic networks and neuroplasticity: can peripheral (eg, 
microbiome) or central (eg, stress) pathways switch ENS networks to change 
symptoms (eg, alternating diarrhea and constipation)? When and how does ENS 
neuroplasticity underlie FGIDs?
5. Psychological stress and the HPA axis/autonomic nervous system response: how 
does it lead to visceral hypersensitivity and alter gut function in FGIDs?
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CNS central nervous system
CRF corticotrophin-releasing factor
DC dendritic cell
EC enterochromaffin
ELA early life adversity
ENS enteric nervous system
FGID functional gastrointestinal disorder
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HPA hypothalamic-pituitary-adrenal
5-HT 5-hydroxytryptamine
IBS irritable bowel syndrome
ICC interstitial cells of Cajal
IEC intestinal epithelial cells
IEL intraepithelial lymphocytes
IL interleukin
ILC innate lymphoid cells
PAG periaqueductal gray
PFC prefrontal cortex
PRR pattern recognition receptor
SERT serotonin-selective reuptake transporter
TLR Toll-like receptor
TRP transient receptor potential
VIP vasoactive intestinal polypeptide
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Figure 1. 
Mechanisms underlying sensitization. Luminal factors and mediators released in response to 
ischemia, injury, and inflammation act on the sensory endings to drive sensitization. These 
peripheral mechanisms are reinforced by central mechanisms in the spinal cord and CNS. 
ATP, adenosine triphosphate; LIF, leukemia inhibitory factor; NGF, nerve growth factor; 
PGE, prostaglandin E; TNF, tumor necrosis factor. Modified from Grundy and Brookes2 
with permission from Morgan and Claypool.
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Figure 2. 
Diagram showing inflammation-induced changes in the propulsive motor circuitry of the 
colon. Modified from Mawe22 with permission from Journal of Clinical Investigation.
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Figure 3. 
Nerves express receptors for immune cell mediators. Immune mediators bind to receptors on 
nerves and can result in either excitation or inhibition of gut function. PAR, protease 
activated receptor; TNF, tumor necrosis factor; TRP, transient receptor potential; TTX-s, 
tetrodotoxin sensitive Na+ channels.
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Figure 4. 
Intestinal barrier structure and function. Adapted with permission from Natividad et al.46 
MAMP, microbe-associated molecular pattern; PRR, pattern recognition receptors.
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Figure 5. 
Chronic psychological stress plays a significant role in the pathophysiology of IBS. CRF, 
corticotropin releasing factor. Reproduced from Barbara et al45 with permission from the 
Journal of Neurogastroenterology Motility.
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